Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2005 3
2006 2
2007 5
2008 3
2009 2
2010 2
2011 1
2012 2
2017 3
2018 1
2019 2
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Functional Alternatives to Alcohol.
Nutt DJ, Tyacke RJ, Spriggs M, Jacoby V, Borthwick AD, Belelli D. Nutt DJ, et al. Among authors: borthwick ad. Nutrients. 2022 Sep 13;14(18):3761. doi: 10.3390/nu14183761. Nutrients. 2022. PMID: 36145137 Free PMC article. Review.
Corrigendum to "Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury" [Bioorg. Med. Chem. Lett. 29(8) (2019) 995-1000].
Goncalves MB, Clarke E, Jarvis CI, Kalindjian SB, Pitcher T, Grist J, Hobbs C, Carlstedt T, Jack J, Brown JT, Mills M, Mumford P, Borthwick AD, Corcoran JPT. Goncalves MB, et al. Among authors: borthwick ad. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2440-2441. doi: 10.1016/j.bmcl.2019.05.058. Epub 2019 Jun 14. Bioorg Med Chem Lett. 2019. PMID: 31208764 Free PMC article. No abstract available.
Discovery and lead optimisation of a potent, selective and orally bioavailable RARβ agonist for the potential treatment of nerve injury.
Goncalves MB, Clarke E, Jarvis CI, Barret Kalindjian S, Pitcher T, Grist J, Hobbs C, Carlstedt T, Jack J, Brown JT, Mills M, Mumford P, Borthwick AD, Corcoran JPT. Goncalves MB, et al. Among authors: borthwick ad. Bioorg Med Chem Lett. 2019 Apr 15;29(8):995-1000. doi: 10.1016/j.bmcl.2019.02.011. Epub 2019 Feb 11. Bioorg Med Chem Lett. 2019. PMID: 30792038 Free PMC article.
Design and synthesis of a potent, highly selective, orally bioavailable, retinoic acid receptor alpha agonist.
Clarke E, Jarvis CI, Goncalves MB, Kalindjian SB, Adams DR, Brown JT, Shiers JJ, Taddei DMA, Ravier E, Barlow S, Miller I, Smith V, Borthwick AD, Corcoran JPT. Clarke E, et al. Among authors: borthwick ad. Bioorg Med Chem. 2018 Feb 15;26(4):798-814. doi: 10.1016/j.bmc.2017.12.015. Epub 2017 Dec 9. Bioorg Med Chem. 2018. PMID: 29288071 Free PMC article.
Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency.
Borthwick AD, Liddle J, Davies DE, Exall AM, Hamlett C, Hickey DM, Mason AM, Smith IE, Nerozzi F, Peace S, Pollard D, Sollis SL, Allen MJ, Woollard PM, Pullen MA, Westfall TD, Stanislaus DJ. Borthwick AD, et al. J Med Chem. 2012 Jan 26;55(2):783-96. doi: 10.1021/jm201287w. Epub 2012 Jan 12. J Med Chem. 2012. PMID: 22239250
Oral oxytocin antagonists.
Borthwick AD. Borthwick AD. J Med Chem. 2010 Sep 23;53(18):6525-38. doi: 10.1021/jm901812z. J Med Chem. 2010. PMID: 20550119 No abstract available.
25 results